Free shipping on all orders over $ 500

CA-170

Cat. No. M14104

All AbMole products are for research use only, cannot be used for human consumption.

CA-170 Structure
Size Price Availability Quantity
5mg USD 420 In stock
10mg USD 670 In stock
25mg USD 1300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes.

Chemical Information
Molecular Weight 360.32
CAS Number 1673534-76-3
Solubility (25°C) DMSO 28.5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Pottayil G Sasikumar, et al. PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

[2] Bogdan Musielak, et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not?

[3] Christine Cuyler, et al. Muskox status, recent variation, and uncertain future

[4] Raphal Paris, et al. Explosive eruption, flank collapse and megatsunami at Tenerife ca. 170 ka

[5] Toru Odate, et al. Anatomy of the levator claviculae, with an overview and a literature survey

Related PD-1/PD-L1 Products
Avelumab (MSB0010718C)

Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). Avelumab recognizes murine PD-L1

Panaxadiol

Panaxadiol exists in ginseng root and has neuroprotective and anti-tumor functions. Panaxadiol inhibits the expression of programmed cell death ligand-1 (PD-L1) and tumor proliferation.

Fraxinellone

Fraxinellone was isolated from the root bark of the brassica family Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor that inhibits HIF-1α synthesis without affecting HIF-1α degradation. Fraxinellone has potential for cancer immunity by targeting PD-L1.

BMS202

Bms-202 is an effective non-peptide PD-1/PD-L complex inhibitor with IC50 of 18 nM and KD of 8 μM. Bms-202 directly binds to PD-L1 and blocks the human PD-1/PD-L interaction. Bms-202 has antitumor activity.

Sulfamethoxypyridazine

Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.

  Catalog
Abmole Inhibitor Catalog




Keywords: CA-170 supplier, PD-1/PD-L1, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.